Following the lead of previous work on mRNA-based vaccines, therapies for spinal cord injuries and more, the method relies upon mineral-coated microparticles to deliver mRNA that encodes for ...

NEW YORK - Tiziana Life Sciences Ltd. (NASDAQ:TLSA), a biotech firm focused on immunomodulation therapies with a market ...

Shares of Tiziana Life Sciences rose after the company said it received positive results from its nasal anti-CD3 monoclonal antibody in traumatic spinal cord injury. The stock was up 5.3% to 84 cents ...

Dr. Saef Izzy, Associate Professor of Neurology at Harvard Medical School, commented, “Treatment with nasal anti-CD3 not only dampened microglial activation but also led to marked improvements in ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its ...

In a new study, scientists at the Leibniz Institute for Neurobiology (LIN) and University Hospital Magdeburg demonstrated that the spinal cord is far more than just a transmission pathway that ...

The family of a 13-year-old filed a federal lawsuit against Mayo Clinic and two orthopedic surgeons, alleging they ...

The family of a 13-year-old North Dakota girl has filed a federal lawsuit against the Mayo Clinic and two orthopedic surgeons, alleging they permanently paralyzed the girl after failing to stabilize ...

According to the team’s results, the BrainGate array wired directly to motor neurons offered a “sixfold improvement” on the ...

Spinal cord injury (SCI) is characterized by the temporary or permanent loss of motion or sensation function caused by damage to the spinal cord. Among the mechanisms behind SCI, neuroinflammation is ...

Explore the role of preclinical MRI in studying neurological diseases, with a focus on advanced cellular and molecular ...

Newsweek spoke to mother Allyson Moulton, 37, who described her teenage daughter's medical condition as a "ticking bomb." ...